David C Mulligan, MD, FACS, FAASLD, FAST

Biography

I have enjoyed an amazing career in solid organ transplantation after residencies in both Urologic and General Surgery followed by an ASTS-approved multiorgan transplant surgical fellowship at Baylor University in Dallas, TX. I received extensive experience in liver, kidney and pancreas transplantation and carried that through a 15 year project to build the highest quality transplant center in the US at Mayo Clinic Arizona from no program and a brand new team to over 3200 solid organ transplants. I was fortunate to direct all these services while continuing to perform the abdominal transplants, hepatic and pancreatic surgery. I was recruited to Yale University to transform a team with amazing research and small to medium size volume into one with outstanding outcomes and growth of transplants and research, which we have been accomplishing to date. My scientific and clinical research covers a broad array from basic science studies of ischemia/reperfusion injury and genomics of chronic allograft nephropathy to clinical modulation of immunosuppression to improve and extend organ function. I established a lab with a team of PhD researchers under the direction of Greg Tietjen to utilize ex-vivo machine perfusion to evaluate and improve donor organ quality for kidney and liver transplantation. I have extensive experience in living donation, especially, living donor liver transplantation, and have not only performed more than 200 living donor hepatectomies, but published our experiences. As a leader, I have the privilege of working in multiple roles within the ASTS, AASLD, AST, and UNOS/OPTN. I served as Chair of the Business Practice Services Committee, Standards and Membership committees of the ASTS, Councilor-at-Large on the Board of Governors of the AASLD, Chair of the Advisory Committee on Transplantation to HHS, and President of UNOS/OPTN. As Director of Transplant Innovation and Technology, I consult worldwide to develop and improve transplantation for all